Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Not applicable Status: Unknown status Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20072
20091
20103
20112
201210
20135
20145
20151
20169
20175
20188
201915
202012
20219
202212
202316
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status123

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shalvata Mental Health Center5
Taipei Medical University5
Massachusetts General Hospital4
Chen Li3
Karolinska Institutet3
The Hong Kong Polytechnic University3
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine3
Fondation Lenval2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
New York University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity123
Anxiety Disorders6
Learning Disabilities5
Mental Disorders3
Neurodevelopmental Disorders3
Stroke3
Autism Spectrum Disorder2
Anemia, Sickle Cell1
Asthma1
Attention Deficit and Disruptive Behavior Disorders1

Trials

Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.